On Dec. 15, 2021, ASTHO released its list of the top 10 state public health policy issues to watch in 2022. Although COVID-19 did not make the “official” list, it is woven into the management plan ...
On Dec. 14, 2021, ASTHO CEO Michael Fraser released a statement with Claire Hannan and Brent Ewig, reflecting on the year since the first COVID-19 vaccine was administered.
On Dec. 14, 2021, ASTHO CEO Michael Fraser released a statement reminding Americans that as we all enjoy the holiday season, it is important that we work together to manage our individual risk, ...
ASTHO works with key partners to support state and territorial health agencies in their role as key leaders in helping citizens prevent heart attacks and strokes.
Primary care practitioners are important allies for public health agencies, and ASTHO provides a portfolio of resources to help reinforce that critical relationship.
The Suicide, Overdose, and Adverse Childhood Experiences Prevention Capacity Assessment Tool (SPACECAT) helps local, state, and territorial health agencies better understand their capacity to address ...
In 2021 ASTHO has been recognized for its efforts advocating for and supporting state and territorial public health leaders via four separate awards by the Alliance for Health Policy, the Center for ...
On Aug. 12, 2021, ASTHO announced that Kimberlee D. Wyche-Etheridge, MD, MPH, will serve as the organization’s senior vice president of health equity and diversity initiatives, effective Oct. 4, 2021.
ASTHO issued a statement of concern for public health and healthcare workers on June 25, 2021, following the publication of a CDC MMWR Early Release, that details the devastating effects of the ...
On July 13, 2021, ASTHO issued a statement of support for President Joe Biden’s nomination of Rahul Gupta, MD, MPH, MBA, FACP, to serve as the Director of the Office of National Drug Control Policy.